Jaguar Animal Health, Inc. (JAGX) vs VistaGen Therapeutics, Inc. (VTGN)
- Jaguar Animal Health, Inc. JAGX 3.53 −23.09%
- VistaGen Therapeutics, Inc. VTGN 0.20 −4.76%
Jaguar Animal Health, Inc. and VistaGen Therapeutics, Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and VistaGen Therapeutics, Inc. are of similar size ($9.5M and $8.9M). VistaGen Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. VistaGen Therapeutics, Inc. grew revenue faster over the last twelve months: 287.2% against 135.5%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −2,703.7%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 19 metrics below, Jaguar Animal Health, Inc. leads on 11 and VistaGen Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | JAGX | VTGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 82.31% | 100.00% | 65.16% |
| Operating margin | (93.10%) | (2,785.69%) | 0.00% |
| Net margin | (188.46%) | (2,703.72%) | 0.00% |
| Free cash flow margin | (24.03%) | (2,490.88%) | 0.00% |
| Return on equity | (1,125.38%) | (166.46%) | (56.36%) |
| Return on assets | (127.14%) | (129.22%) | (48.04%) |
| Return on invested capital | (28,393.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack